🎗️ OncologyCapsule
Brukinsa
Zanubrutinib
Second-generation BTK inhibitor for B-cell malignancies including CLL, SLL, and mantle cell lymphoma.
Form
Capsule
Uses
4
Side effects
5
Category
Oncology
01
What is Brukinsa used for?
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- Waldenström macroglobulinemia
- Mantle cell lymphoma
02
Zanubrutinib side effects
The following side effects have been reported for Zanubrutinib. Their order does not indicate how often an effect occurs.
Neutropenia
Infection
Hemorrhage
Atrial fibrillation
Thrombocytopenia
03
Zanubrutinib warnings & precautions
- Hemorrhage risk
- Atrial fibrillation and flutter risk
- Serious infections. Monitor for fever
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Brukinsa in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.